hotspot -WSS

hotspot

author：hotspot 2025-10-01 16:42:44 - browse：41

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： The drug industry sees a key ally in the Senate prevail

WSS

Emergency workers more likely to restrain Black patients: study

Senate HELP committee spars over health care workforce policies

Thermo Fisher plant for manufacturing gene therapies to expand

Hearing on Medicare drug price negotiation gets unusually heated

Readout LOUD podcast: possible new ALS drug, artificial wombs

The drug industry sees a key ally in the Senate prevail

explore

hotspot

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Thermo Fisher plant for manufacturing gene therapies to expand

Activists slam private health insurers over coverage restrictions

For BCIs, commercial hurdles may be bigger than scientific ones

ChatGPT in medicine: STAT answers readers' burning questions

CDC advisers recommend seasonal use of Pfizer RSV shot

Continuity nursing helped my family in our darkest PICU moments

Senators: Long

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Stem cell clinics for heart failure: buyer be wary

leisure time

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Intarcia’s device

OTC birth control: A brief history of over the counter pill design

Gilgo Beach: Police identify another victim in serial killing investigation

2 US Navy sailors arrested for allegedly spying for China

Microsoft strikes partnership with Duke Health to advance health AI

entertainment

explore

knowledge

entertainment